A Phase I Study of BI 811283, an Aurora B Kinase Inhibitor, in Patients With Advanced Solid Tumors
Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-016-3095-6
Full Text
Open PDFAbstract
Available in full text
Date
June 27, 2016
Authors
Publisher
Springer Science and Business Media LLC